Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q87399775
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010741.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q87399775
|
024
|
|
|
‡a
0000-0003-4622-618X
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q87399775
|
100
|
0 |
|
‡a
Ivan O Rosas
‡c
researcher
‡9
en
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Ivan O Rosas
‡c
wetenschapper
‡9
nl
|
670
|
|
|
‡a
Author's A comparison of visual and quantitative methods to identify interstitial lung abnormalities
|
670
|
|
|
‡a
Author's ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
|
670
|
|
|
‡a
Author's Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation
|
670
|
|
|
‡a
Author's Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation
|
670
|
|
|
‡a
Author's Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
|
670
|
|
|
‡a
Author's Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes
|
670
|
|
|
‡a
Author's Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis
|
670
|
|
|
‡a
Author's Genetics and early detection in idiopathic pulmonary fibrosis
|
670
|
|
|
‡a
Author's Interstitial lung abnormalities and reduced exercise capacity
|
670
|
|
|
‡a
Author's Lung volumes and emphysema in smokers with interstitial lung abnormalities
|
670
|
|
|
‡a
Author's Mitochondrial antiviral signalling protein is crucial for the development of pulmonary fibrosis
|
670
|
|
|
‡a
Author's Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities
|
670
|
|
|
‡a
Author's Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease
|
670
|
|
|
‡a
Author's Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
|
670
|
|
|
‡a
Author's Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation
|
670
|
|
|
‡a
Author's Subclinical interstitial lung disease: why you should care
|
670
|
|
|
‡a
Author's Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models
|
909
|
|
|
‡a
(orcid) 000000034622618x
‡9
1
|
919
|
|
|
‡a
subclinicalinterstitiallungdiseasewhyyoushouldcare
‡A
Subclinical interstitial lung disease: why you should care
‡9
1
|
919
|
|
|
‡a
statinsandpulmonaryfibrosisthepotentialroleofnlrp3inflammasomeactivation
‡A
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation
‡9
1
|
919
|
|
|
‡a
singlecellrnaseqrevealsectopicandaberrantlungresidentcellpopulationsinidiopathicpulmonaryfibrosis
‡A
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
‡9
1
|
919
|
|
|
‡a
shorttelomerestelomeropathyandsubclinicalextrapulmonaryorgandamageinpatientswithinterstitiallungdisease
‡A
Short telomeres, telomeropathy, and subclinical extrapulmonary organ damage in patients with interstitial lung disease
‡9
1
|
919
|
|
|
‡a
paraseptalemphysemaprevalenceanddistributiononctandassociationwithinterstitiallungabnormalities
‡A
Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities
‡9
1
|
919
|
|
|
‡a
mitochondrialantiviralsignallingproteiniscrucialforthedevelopmentofpulmonaryfibrosis
‡A
Mitochondrial antiviral signalling protein is crucial for the development of pulmonary fibrosis
‡9
1
|
919
|
|
|
‡a
lungvolumesandemphysemainsmokerswithinterstitiallungabnormalities
‡A
Lung volumes and emphysema in smokers with interstitial lung abnormalities
‡9
1
|
919
|
|
|
‡a
interstitiallungabnormalitiesandreducedexercisecapacity
‡A
Interstitial lung abnormalities and reduced exercise capacity
‡9
1
|
919
|
|
|
‡a
geneticsandearlydetectioninidiopathicpulmonaryfibrosis
‡A
Genetics and early detection in idiopathic pulmonary fibrosis
‡9
1
|
919
|
|
|
‡a
functionalimpactofaspectrumofinterstitiallungabnormalitiesinrheumatoidarthritis
‡A
Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis
‡9
1
|
919
|
|
|
‡a
extensivecitrullinationpromotesimmunogenicityofhsp90throughproteinunfoldingandexposureofcrypticepitopes
‡A
Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes
‡9
1
|
919
|
|
|
‡a
detectionofrheumatoidarthritisinterstitiallungdiseaseisenhancedbyserumbiomarkers
‡A
Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.
‡9
1
|
919
|
|
|
‡a
circulatingmitochondrialdnainpatientsintheicuasamarkerofmortalityderivationandvalidation
‡A
Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation
‡9
1
|
919
|
|
|
‡a
agedependentsusceptibilitytopulmonaryfibrosisisassociatedwithnlrp3inflammasomeactivation
‡A
Age-Dependent Susceptibility to Pulmonary Fibrosis Is Associated with NLRP3 Inflammasome Activation
‡9
1
|
919
|
|
|
‡a
targetedinhibitionofpi3kinasemtorspecificallyinfibroticlungfibroblastssuppressespulmonaryfibrosisinexperimentalmodels
‡A
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models
‡9
1
|
919
|
|
|
‡a
actriiafcrebalancesactivingdfversusbmpsignalinginpulmonaryhypertension
‡A
ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
‡9
1
|
919
|
|
|
‡a
comparisonofvisualandquantitativemethodstoidentifyinterstitiallungabnormalities
‡A
A comparison of visual and quantitative methods to identify interstitial lung abnormalities
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BNE|XX1515046
|
996
|
|
|
‡2
SUDOC|24369654X
|
996
|
|
|
‡2
DNB|1205076565
|
996
|
|
|
‡2
ISNI|0000000044902269
|
996
|
|
|
‡2
ARBABN|000049021
|
996
|
|
|
‡2
DNB|1289101450
|
996
|
|
|
‡2
RERO|A003759525
|
996
|
|
|
‡2
DNB|118602586
|
996
|
|
|
‡2
J9U|987007267236205171
|
996
|
|
|
‡2
BNC|981058609780406706
|
996
|
|
|
‡2
NTA|130555320
|
996
|
|
|
‡2
NII|DA09255113
|
996
|
|
|
‡2
LC|n 85815411
|
996
|
|
|
‡2
N6I|vtls001225143
|
996
|
|
|
‡2
NTA|06970192X
|
996
|
|
|
‡2
SUDOC|250379945
|
996
|
|
|
‡2
BNCHL|10000000000000000013408
|
996
|
|
|
‡2
LC|no2011133646
|
996
|
|
|
‡2
ISNI|0000000028288203
|
996
|
|
|
‡2
NYNYRILM|86050
|
996
|
|
|
‡2
ISNI|0000000019469627
|
996
|
|
|
‡2
LC|no2017003352
|
996
|
|
|
‡2
BNE|XX4672165
|
996
|
|
|
‡2
LC|n 91015878
|
996
|
|
|
‡2
SUDOC|168998408
|
996
|
|
|
‡2
LC|no2020069098
|
996
|
|
|
‡2
LC|n 2021055285
|
996
|
|
|
‡2
ARBABN|000022751
|
996
|
|
|
‡2
BNF|12133790
|
996
|
|
|
‡2
RERO|A018338471
|
996
|
|
|
‡2
LC|n 50082051
|
996
|
|
|
‡2
LC|no2006116693
|
996
|
|
|
‡2
ISNI|0000000392787164
|
996
|
|
|
‡2
SUDOC|029787475
|
996
|
|
|
‡2
DNB|1051353319
|
996
|
|
|
‡2
BIBSYS|8070311
|
996
|
|
|
‡2
BNCHL|10000000000000000871493
|
996
|
|
|
‡2
SZ|118602586
|
996
|
|
|
‡2
ISNI|0000000121334956
|
996
|
|
|
‡2
ISNI|0000000029621565
|
996
|
|
|
‡2
DNB|1060561999
|
996
|
|
|
‡2
BNC|981058609796306706
|
996
|
|
|
‡2
LC|no2014084253
|
996
|
|
|
‡2
LC|n 2016002017
|
996
|
|
|
‡2
DNB|1204569436
|
996
|
|
|
‡2
BIBSYS|90155419
|
996
|
|
|
‡2
PTBNP|1843553
|
996
|
|
|
‡2
DNB|1323164820
|
996
|
|
|
‡2
LC|n 2012073801
|
996
|
|
|
‡2
PLWABN|9810699245205606
|
996
|
|
|
‡2
LC|n 00099329
|
996
|
|
|
‡2
CAOONL|ncf11221248
|
996
|
|
|
‡2
CAOONL|ncf11888788
|
996
|
|
|
‡2
ISNI|0000000456976512
|
996
|
|
|
‡2
BLBNB|000337028
|
996
|
|
|
‡2
BAV|495_198384
|
996
|
|
|
‡2
BNC|981058602352306706
|
996
|
|
|
‡2
BNE|XX1139839
|
996
|
|
|
‡2
NLA|000035690395
|
996
|
|
|
‡2
BNC|981058516792306706
|
996
|
|
|
‡2
SUDOC|276597168
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|